(Q43278795)

English

Potent and selective agonism of the melanocortin receptor 4 with MK-0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy

scientific article published on 9 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 November 2017

Potent and selective agonism of the melanocortin receptor 4 with MK-0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy (English)

1 reference

Europe PubMed Central

18 November 2017

0 references

human subject research project

0 references

John Edward Blundell

object named as

J Blundell

16

0 references

author name string

R Krishna

1

1 reference

Europe PubMed Central

18 November 2017

B Gumbiner

2

1 reference

Europe PubMed Central

18 November 2017

C Stevens

3

1 reference

Europe PubMed Central

18 November 2017

B Musser

4

1 reference

Europe PubMed Central

18 November 2017

M Mallick

5

1 reference

Europe PubMed Central

18 November 2017

S Suryawanshi

6

1 reference

Europe PubMed Central

18 November 2017

L Maganti

7

1 reference

Europe PubMed Central

18 November 2017

H Zhu

8

1 reference

Europe PubMed Central

18 November 2017

T H Han

9

1 reference

Europe PubMed Central

18 November 2017

L Scherer

10

1 reference

Europe PubMed Central

18 November 2017

B Simpson

11

1 reference

Europe PubMed Central

18 November 2017

D Cosgrove

12

1 reference

Europe PubMed Central

18 November 2017

K Gottesdiener

13

1 reference

Europe PubMed Central

18 November 2017

J Amatruda

14

1 reference

Europe PubMed Central

18 November 2017

B J Rolls

15

1 reference

Europe PubMed Central

18 November 2017

G A Bray

17

1 reference

Europe PubMed Central

18 November 2017

K Fujioka

18

1 reference

Europe PubMed Central

18 November 2017

S B Heymsfield

19

1 reference

Europe PubMed Central

18 November 2017

J A Wagner

20

1 reference

Europe PubMed Central

18 November 2017

G A Herman

21

1 reference

Europe PubMed Central

18 November 2017

language of work or name

0 references

publication date

9 September 2009

1 reference

Europe PubMed Central

18 November 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

18 November 2017

86

1 reference

Europe PubMed Central

18 November 2017

6

1 reference

Europe PubMed Central

18 November 2017

659-666

1 reference

Europe PubMed Central

18 November 2017

Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

Obesity-associated mutations in the melanocortin 4 receptor provide novel insights into its function

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

Targeted disruption of the melanocortin-4 receptor results in obesity in mice

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

Association between an agouti-related protein gene polymorphism and anorexia nervosa

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

Agouti-related protein promoter variant associated with leanness and decreased risk for diabetes in West Africans

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

Long-term weight loss with sibutramine: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

Sibutramine pharmacokinetics in young and elderly healthy subjects.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

Modulation of blood pressure by central melanocortinergic pathways

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

The ultimate model organism: progress in experimental medicine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

Ala67Thr polymorphism in the Agouti-related peptide gene is associated with inherited leanness in humans

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

21 January 2018

Two ethnic-specific polymorphisms in the human Agouti-related protein gene are associated with macronutrient intake

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of melanocortins in body weight regulation: opportunities for the treatment of obesity

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Sibutramine reduces food intake in non-dieting women with obesity

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Thermogenic effects of sibutramine in humans

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Modalities of the food intake-reducing effect of sibutramine in humans

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2009.167

1 reference

Europe PubMed Central

18 November 2017

1 reference

Europe PubMed Central

18 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43278795&oldid=1985520185"